866-997-4948(US-Canada Toll Free)

Toxoplasmosis Global Clinical Trials Review, H2, 2014

Published By :

GlobalData

Published Date : Dec 2014

Category :

Clinical Trials

No. of Pages : 60 Pages


GlobalData's clinical trial report, Toxoplasmosis Global Clinical Trials Review, H2, 2014" provides data on the Toxoplasmosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Toxoplasmosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Toxoplasmosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents 2
List of Tables 3
List of Figures 4

Introduction 5
Toxoplasmosis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Toxoplasmosis to Infectious Disease Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Toxoplasmosis to Infectious Disease Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Glaxo Wellcome GmbH & Co. KG 27
Clinical Trial Overview of Glaxo Wellcome GmbH & Co. KG 27
Clinical Trial Overview of Top Institutes / Government 28
The National Institute of Allergy and Infectious Diseases 28
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 28
Renmin Hospital of Wuhan University 29
Clinical Trial Overview of Renmin Hospital of Wuhan University 29
Zentrum fur Integrative Psychiatrie 30
Clinical Trial Overview of Zentrum fur Integrative Psychiatrie 30
Rafik Hariri University Hospital 31
Clinical Trial Overview of Rafik Hariri University Hospital 31
Palo Alto Medical Foundation for Health Care, Research & Education 32
Clinical Trial Overview of Palo Alto Medical Foundation for Health Care, Research & Education 32
Arak University of Medical Sciences 33
Clinical Trial Overview of Arak University of Medical Sciences 33
University of Campinas, Brazil 34
Clinical Trial Overview of University of Campinas, Brazil 34
University Hospital, Limoges 35
Clinical Trial Overview of University Hospital, Limoges 35
National Institutes of Health Clinical Center 36
Clinical Trial Overview of National Institutes of Health Clinical Center 36
Assistance Publique - Hopitaux de Paris 37
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 37
Five Key Clinical Profiles 38

Appendix 58
Abbreviations 58
Definitions 58
Research Methodology 59
Secondary Research 59
About GlobalData 60
Contact Us 60
Disclaimer 60
Source 60

List of Table


Toxoplasmosis Therapeutics, Global, Clinical Trials by Region, 2014* 6
Toxoplasmosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Toxoplasmosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Toxoplasmosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Toxoplasmosis Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Toxoplasmosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Toxoplasmosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Toxoplasmosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Toxoplasmosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 14
Toxoplasmosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Toxoplasmosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Toxoplasmosis to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 17
Toxoplasmosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Toxoplasmosis Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Toxoplasmosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Toxoplasmosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Toxoplasmosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Toxoplasmosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Toxoplasmosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Toxoplasmosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Toxoplasmosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Glaxo Wellcome GmbH & Co. KG, 2014* 27
Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 28
Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Renmin Hospital of Wuhan University, 2014* 29
Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zentrum fur Integrative Psychiatrie, 2014* 30
Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rafik Hariri University Hospital, 2014* 31
Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Palo Alto Medical Foundation for Health Care, Research & Education, 2014* 32
Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Arak University of Medical Sciences, 2014* 33
Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Campinas, Brazil, 2014* 34
Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Limoges, 2014* 35
Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2014* 36
Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 37

List of Chart


Toxoplasmosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Toxoplasmosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Toxoplasmosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Toxoplasmosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Toxoplasmosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 12
Proportion of Toxoplasmosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 14
Toxoplasmosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Toxoplasmosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Toxoplasmosis to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 17
Toxoplasmosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Toxoplasmosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Toxoplasmosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Toxoplasmosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Toxoplasmosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Toxoplasmosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Toxoplasmosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Toxoplasmosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 59

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *